pyrazole has been researched along with am 251 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krishnamurthy, M; Li, W; Moore, BM | 1 |
Fong, O; Fong, TM; Muise, ES; Qian, S; Thompson, JR; Weingarth, D; Zhao, W | 1 |
2 other study(ies) available for pyrazole and am 251
Article | Year |
---|---|
Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.
Topics: Animals; Biochemistry; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Humans; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2004 |
Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters.
Topics: Adipose Tissue; Animals; Cannabinoid Receptor Agonists; Down-Regulation; Homozygote; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Knockout; Mice, Obese; Piperidines; PPAR alpha; PPAR gamma; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Transcriptional Activation | 2010 |